Clinical Trial Update: Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating injections of botulinum toxin type A (Xeomin) into the rectus femoris and soleus muscles to improve gait in individuals with h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Traumatic Brain Injury

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hemiparesis After Stroke, Traumatic Brain Injury | Phase 2 | Status: UNKNOWN